2022-12-02 06:24:40 GSK GSK
12/02/22 12/0206:24 12/02/2206:24 | GSK's phase 3 trial of Jemperli meets primary endpointThe company states: "GSK announced positive headline results from the planned interim analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial investigating Jemperli plus standard-of-care chemotherapy, carboplatin-paclitaxel, followed by Jemperli compared to chemotherapy plus placebo followed by placebo in adult patients with primary advanced or recurrent endometrial cancer. The trial met its primary endpoint of investigator-assessed progression-free survival. It showed a statistically significant and clinically meaningful benefit in the prespecified mismatch repair deficient microsatellite instability-high patient subgroup and in the overall population. A clinically relevant benefit in PFS was also observed in the mismatch repair proficient microsatellite stable patient subgroup. While the overall survival (OS) data were immature at the time of this analysis, a favourable trend was observed in the overall population, including both the dMMR/MSI-H and MMRp/MSS subgroups. The safety and tolerability profile of dostarlimab in the RUBY phase III trial was consistent with clinical trials of similar regimens. The most common treatment-emergent adverse events in patients receiving dostarlimab plus chemotherapy were nausea, alopecia, fatigue, peripheral neuropathy, anaemia, arthralgia, constipation and diarrhoea." Hesham Abdullah, Senior Vice President, Global Head of Oncology Development, GSK said: "Patients with primary advanced or recurrent endometrial cancer have limited treatment options. Long-term outcomes remain poor, and new treatment options are urgently needed to evolve the current standard of care, which is platinum-based chemotherapy. Based on these positive headline results from the RUBY phase III trial, GSK intends to seek regulatory approvals for a potential new indication for dostarlimab in the treatment of primary advanced or recurrent endometrial cancer."Reference Link |
---|
Hot Stocks
|
Brookfield Reinsurance to acquire Argo Group in $1.1B transaction
08:33 02/08/23 02/0808:33 02/08/2308:33
BNRE
Brookfield Reinsurance
Argo Group
ShowHide Related Items >><<
|
Recommendations
|
Jacobs price target lowered to $155 from $161 at Credit Suisse »
08:32 02/08/23 02/0808:32 02/08/2308:32
J
Jacobs
Credit Suisse analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Uber expects to generate $1B in ad revenue in 2023
08:32 02/08/23 02/0808:32 02/08/2308:32
UBER
Uber
ShowHide Related Items >><<
|
Syndicate
|
Dynatrace 15M share Spot Secondary priced at $45.55 »
08:32 02/08/23 02/0808:32 02/08/2308:32
DT
Dynatrace
The deal priced at the… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Uber sees West Coast trips approaching pre-Covid levels
08:32 02/08/23 02/0808:32 02/08/2308:32
UBER
Uber
ShowHide Related Items >><<
|
Recommendations
|
Pinterest price target raised to $24 from $21 at DA Davidson »
08:32 02/08/23 02/0808:32 02/08/2308:32
PINS
DA Davidson analyst Tom… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Quantum Computing awarded subcontract from SSAI to support NASA »
08:32 02/08/23 02/0808:32 02/08/2308:32
QUBT
Quantum Computing
Quantum Computing… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Argo Group trading halted, news pending
08:30 02/08/23 02/0808:30 02/08/2308:30
ARGO
Argo Group
ShowHide Related Items >><<
|
Hot Stocks
|
ARGO GROUP US INC 6.5% SR NTS 42 trading halted, news pending
08:30 02/08/23 02/0808:30 02/08/2308:30
|
Hot Stocks
|
Teva sees FY23 free cash flow $1.7B-$2.1B »
08:29 02/08/23 02/0808:29 02/08/2308:29
TEVA
Teva
Sees FY23 capital… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Meta Platforms price target raised to $188 from $165 at Loop Capital »
08:28 02/08/23 02/0808:28 02/08/2308:28
META
Meta Platforms
Loop Capital analyst Rob… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
BellRing Brands price target raised to $32 from $30 at Morgan Stanley »
08:27 02/08/23 02/0808:27 02/08/2308:27
BRBR
BellRing Brands
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
DJ Transportation Average: Pivot points »
08:27 02/08/23 02/0808:27 02/08/2308:27
$DJT
DJ Transportation Average
The following are the… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
| The following are the… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
Dow Jones Industrial Average: Pivot points »
08:27 02/08/23 02/0808:27 02/08/2308:27
DJX
Dow Jones Industrial Average
The following are the… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
iShares Transportation Average: Pivot points »
08:26 02/08/23 02/0808:26 02/08/2308:26
IYT
iShares Transportation Average
The following are the… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Oak Street Health downgraded to In Line from Outperform at Evercore ISI »
08:26 02/08/23 02/0808:26 02/08/2308:26
OSH
Oak Street Health
Evercore ISI analyst… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
Technology Select Sector SPDR: Pivot points »
08:26 02/08/23 02/0808:26 02/08/2308:26
XLK
Technology Select Sector SPDR
The following are the… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
Energy Select Sector SPDR: Pivot points »
08:26 02/08/23 02/0808:26 02/08/2308:26
XLE
Energy Select Sector SPDR
The following are the… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
Consumer Discretionary Sector SPDR: Pivot points »
08:26 02/08/23 02/0808:26 02/08/2308:26
XLY
Consumer Discretionary Sector SPDR
The following are the… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
S&P Select Materials SPDR: Pivot points »
08:25 02/08/23 02/0808:25 02/08/2308:25
XLB
S&P Select Materials SPDR
The following are the… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Chipotle price target lowered to $1,800 from $1,825 at Truist »
08:25 02/08/23 02/0808:25 02/08/2308:25
CMG
Chipotle
Truist analyst Jake… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
Utilities SPDR: Pivot points »
08:25 02/08/23 02/0808:25 02/08/2308:25
XLU
Utilities SPDR
The following are the… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
Consumer Staples Sector SPDR: Pivot points »
08:25 02/08/23 02/0808:25 02/08/2308:25
XLP
Consumer Staples Sector SPDR
The following are the… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
Health Care Select Sector SPDR: Pivot points »
08:25 02/08/23 02/0808:25 02/08/2308:25
XLV
Health Care Select Sector SPDR
The following are the… Story temporarily locked. ShowHide Related Items >><<
|